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After acute inflammation or infection, tissue-resident macrophages are replaced by inflammatory DCs and
effector macrophages that arise from circulating monocytes. In this issue of Immunity, Goldszmid et al.
(2012) demonstrate a central role for NK cell-derived IFN-g in signaling and facilitating this transition.Inflammation—initiated by either sterile or
infectious stimuli—is associated with the
recruitment of circulating CCR2-depen-
dent monocytes to the site of tissue injury
and infection (Ingersoll et al., 2011). In the
spleen of Listeria-infected mice, recruited
CCR2-dependent monocytes have been
shown to differentiate into tumor necrosis
factor (TNF) and inducible NO synthase
(iNOS)-producing dendritic cells (DCs) or
so-called TipDCs, which exhibit potent
antimicrobial effector functions against
bacterial infection (Serbina et al., 2003).
Cells resembling TipDCs have been
observed during experimental infections
by viral (influenza, herpes simplex
virus 2), bacterial (Salmonella, Brucella
melitensis), fungal (Aspergillus fumigatus
and Blastomyces dermatitidis), and para-
sitic (Leishmania major and Toxoplasma
gondii) agents. After oral inoculation of
T. gondii cysts, CCR2-dependent mono-
cytes are rapidly recruited to the villi of
the small intestine where the excysted
parasites initiate the infectious process.
Inflammatory monocytes differentiate—
presumably in response to local parasite-
and tissue-derived factors—into F4/80+
Ly6Chi but CD11clo macrophages with
the ability to express TNF and iNOS and
mediate restriction of Toxoplasma repli-
cation in the gut (Dunay et al., 2008). In
addition to mediating antimicrobial resis-
tance, inflammatory monocytes have
also been shown to differentiate into clas-
sical CD11c+ dendritic cells. In Leish-
mania major infection, monocyte-derived
DCs migrate from the skin and contribute
to the generation of protective Th1 cells
in the lymph node (Leo´n et al., 2007). In
contrast, these cells are dispensable for
the priming of Th1 cell responses to
HSV-2 but are crucial for restimulation904 Immunity 36, June 29, 2012 ª2012 Elsevof effector Th1 cells in the vaginal
mucosa (Iijima et al., 2011). Although
the roles of CCR2 signaling chemokines
in regulating monocyte egress from the
bone marrow and their subsequent
recruitment into inflamed tissues have
been investigated, the microenviron-
mental signals driving monocyte differen-
tiation into antimicrobial effector cells or
Th1 cell-promoting DCs have remained
elusive. Now, Goldszmid et al. (2012)
identify a local positive feedback mecha-
nism that promotes the differentiation of
migratory monocytes into DCs express-
ing IL-12. They identify IFN-g—the very
end product of the Th1 cell response
cascade—as the critical inducer of the
inflammatory DC phenotype. Surpris-
ingly, IFN-g signaling is itself required
for the attrition of the resident macro-
phage population and thus serves as a
switch for the tissue transitioning from
a homeostatic to an inflammatory state
(Figure 1).
Given the centrality of IL-12 in driving
protective Th1 cell and CD8+ T cell
effector responses to T. gondii, the
authors started their work by focusing
on the identity of the IL-12-producing
cell at the site of T. gondii inoculation.
Prior studies using in vivo injections of
a soluble extract of the parasite have
identified CD8a+ DCs in the T cell zone
as spleen-resident innate cells mounting
an immediate IL-12 response (Reis
e Sousa et al., 1997). Indeed, with the
recent studies of T. gondii infection in
the Batf3-deficient mice (which lack
CD8a+ and CD103+ DC subsets), the crit-
ical role of CD8a+ DCs in producing the
initial burst of IL-12 required for priming
Th1 cell responses to T. gondii has now
been affirmed (Mashayekhi et al., 2011).ier Inc.However, the nature of the IL-12-
producing cell present at the infection
site, where effector Th1 cell responses
are needed to restrain parasite replica-
tion, is not known. To address this issue,
the authors took advantage of a previ-
ously constructed IL-12p40 reporter
mouse strain and utilized an intraperito-
neal route of inoculation of intact parasite
cysts. Different from the natural peroral
route, this experimental system allowed
them to sample the infection site and
characterize the phenotype of the IL-12-
producing cells present in the peritoneal
cavity, without need for tissue digestion
or cell purification, and, importantly, with-
out the additional confounding effects of
innate cell exposure to the encroaching
gut microbiome. Adoptive transfer of
monocytes isolated from the bone
marrow of the IL-12p40 reporter strain
also allowed tracking and detailed anal-
ysis of how acquisition of the IL-12-
producing phenotype is controlled as
recruited precursors differentiate into
inflammatory DCs.
Based on these approaches, Gold-
szmid et al. (2012) make several important
observations and tantalizing insights.
First, IL-12 expression was restricted to
F4/80+ CD8a-inflammatory DCs whereas
resident macrophages remained IL-12
negative and became superceded by
the influx of neutrophils, inflammatory
macrophages, and DCs. The authors
subsequently investigated the mono-
cyte-autonomous roles of IFN-g and
MyD88 signaling. They find that both are
required for IL-12 production by inflam-
matory DCs. This result is, on its surface,
predictable, given the documented role
of TLR11 in innate sensing of T. gondii
and the well-known priming effect of
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Figure 1. NK Cell-Derived IFN-g Signals Removal of Resident Macrophages and Local
Differentiation of Recruited Monocytes into IL-12-Producing Inflammatory DCs and Effector
Macrophages
LyC6+CCR2+ inflammatory monocytes are recruited to the peritoneal cavity of mice infected with
Toxoplasma cysts and differentiate into inflammatory macrophages and monocyte-derived DCs. Mo-DCs
are the main source of IL-12 at the site of infection and require IFN-g andMyD88 signals for IL-12 produc-
tion. IFN-g, derived from NK cells, is also required for the removal of resident macrophages and the
expression of macrophage and DCmaturation markers in monocyte-derived cells. As the main producers
of IL-12, Mo-DCs might be important for the priming and/or restimulation of Th1 cell responses at the
infection site.
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the IL-12p40 gene. However, the finding
that ablation of IFN-g signaling results in
a more severe curtailment of maturation
and IL-12 production is unanticipated. In
the absence of IFN-g, recruited mono-
cytes still differentiated into CD11c+ DCs
but did not exhibit the mature Ly6ChiF4/
80+IL-12+ inflammatory phenotype. This
dissociation indicates that additional
growth factors or cytokines provide differ-
entiative signals distinct from the matu-
rational effects of IFN-g and TLR en-
gagement. Thus, depending upon which
complement of hemopoietic growth
factors the recruited monocytes en-
counter, they might differentiate into
either macrophages or DCs. Subse-
quently, synergistic activation by endoge-
nous IFN-g and pathogen-derived ligands
could then represent a shared pathway
for arming and licensing macrophages
and DCs into antimicrobial effectors and
proinflammatory antigen-presenting cells
(APCs).
A most fascinating aspect of this work
relates to the behavior of the resident
macrophage population that first encoun-
ters T. gondii. Why these cells fail to
mount an IL-12 response remains
a mystery. It is possible that they do not
express the requisite components (e.g.,TLR 11, Irf8) essential for pathogen
sensing and transcription of the IL-12
genes. Apparently, IFN-g exposure of
these pre-existing sentinels does not
trigger the same maturational effects
observed in the migrant-derived DC and
macrophage populations. Instead of acti-
vating resident macrophages, IFN-g initi-
ates a cascade of events leading to their
attrition. The IFN-g-dependent mecha-
nisms responsible for their disappearance
are unclear and need to be worked out.
Whether resident macrophages are direct
targets of IFN-g signaling and the
modality of resident macrophage cell
death are two outstanding issues that
require further probing.
To provide a glimpse into the matura-
tional program initiated by IFN-g signaling
resulting in IL-12 production and acquisi-
tion of antigen-presenting function by
inflammatory DCs, Goldszmid et al.
(2012) compared the gene expression
profiles of sorted CD11c+ inflammatory
DCs obtained from infected mice under
IFN-g-sufficient and -deficient conditions.
Consistent with their phenotypic analysis,
neutralization of IFN-g in vivo led to
suppression of only a limited subset of
genes necessary for antigen presentation
and IL-12 production. Whereas DC
expression of Ciita, Ccr7, and Cd70 wasImmunityIFN-g independent, IFN-g blockade led
to suppression of Cd86 and Irf8 expres-
sion. Given that Irf8 is essential for the
development of IL-12-producing CD8a+
DCs (Aliberti et al., 2003), the principal
effect of IFN-g signaling could be to acti-
vate the latent Th1 cell promoting poten-
tial of inflammatory DC precursors
through induction of Irf8 and (potentially)
T-bet. The current work leaves open
questions regarding the relative impor-
tance of these inflammatory IL-12+ DCs
in priming versus subsequent restimula-
tion of Th1 cells in the spleen and at the
peripheral effector site. It could well be
that, in the case of T. gondii, there is
a division of labor among DC subsets,
with CD8a+ DCs serving as the priming
APCs in the spleen and the monocyte-
derived inflammatory DCs acting as prin-
cipal APCs in the periphery. As alluded
to above, the contribution of inflammatory
DCs to the initial priming of T cells will
probably vary depending upon factors
inherent to the biology of the infectious
agent and its route of invasion or trans-
mission, perhapswith an enhanced prom-
inence of the inflammatory DC’s priming
role at mucosal sites such as the lung
(Hohl et al., 2009).
Viewed from a broader perspective, the
finding that NK cell-derived IFN-g plays
a key role in programming the Th1 cell-
promoting functional module within
inflammatory DCs suggests a general
paradigm for how early production of the
archetypal Th1 and Th2 cell-type cyto-
kines by innate lymphoid cells conditions
the development of migrant monocytes
into antigen-presenting cell type required
for subsequent induction or amplification
of the appropriately matched adaptive
immune responses.REFERENCES
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